Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Individualized brain stimulation for treating insomnia

Official title: Model-Driven Individualized Transcranial Direct Current Stimulation for the Treatment of Insomnia Disorders

Run by Shanghai Mental Health Center · NCT06671457 · Data updated 2026-11-12

This study is testing whether personalized brain stimulation can help people with insomnia sleep better.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment40 (estimated)
SponsorShanghai Mental Health Center
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedNovember 10, 2024
Main results expectedMarch 1, 2026
Study endsApril 1, 2026
Registry record updatedAugust 21, 2025
Trial IDNCT06671457 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 65 who meet the diagnostic criteria for insomnia disorder and have a severity score indicating significant insomnia.

Probably not a fit

Patients with other primary psychiatric disorders, severe anxiety or depression, or those currently using benzodiazepines may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of individualized transcranial direct current stimulation (tDCS) for patients suffering from insomnia. It utilizes a randomized double-blind placebo-controlled design, involving 40 participants who are assigned to either an active or sham stimulation group. Participants undergo clinical assessments, MRI scans, and EEG parameter collections to tailor the stimulation parameters specifically to their needs. The stimulation sessions are conducted over two weeks, with each session lasting thirty minutes.

Why it matters

Potential benefit: If successful, this approach could provide a novel, non-pharmacological treatment option for patients with insomnia.

How similar studies have gone: While the use of tDCS is gaining interest, this specific individualized approach is relatively novel and has not been extensively tested in similar studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age between 18 and 65 years;
2. Meets the diagnostic criteria for insomnia disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
3. Has not taken psychiatric medications in the 8 weeks prior to enrollment or has been on stable psychiatric medication for 8 weeks (excluding benzodiazepines);
4. Insomnia severity as indicated by an ISI score \> 10;
5. Minimum education level of junior high school or above.

Exclusion Criteria:

1. Past or current diagnosis of disorders other than insomnia disorder, anxiety disorder, or depressive disorder according to DSM-5;
2. Currently using benzodiazepines as sleep aids;
3. Moderate to severe anxiety or depression (HAMD-17 score \> 16 or HAMA score \> 24);
4. Patients with obstructive sleep apnea syndrome;
5. Previous treatment with ECT, rTMS, tES, or cognitive behavioral therapy for insomnia disorder;
6. Severe physical illnesses or any condition that may induce seizures or intracranial hypertension, including cardiovascular or respiratory diseases;
7. History of neurological disorders (e.g., epilepsy, cerebrovascular accidents) or history of brain injury or brain surgery;
8. Presence of implantable medical devices such as intracranial stents, cardiac pacemakers, coronary stents, or cochlear implants;
9. Severe negative thoughts or high suicide risk;
10. Pregnant or planning to conceive in the near future.

Where it's running

  • Shanghai Mental Health Center
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Zhen Wang, PhD,MD — Shanghai Mental Health Center
  • Study coordinator: Zhen Wang, PhD,MD
  • Email: wangzhen@smhc.org.cn
  • Phone: +86 34773516

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.